Verrica Pharma

$8.10 0.00% ($0.00)

Get ready to invest

About Verrica Pharma

Verrica Pharmaceuticals Inc. is a United States-based clinical-stage medical dermatology company. The Company is focused on identifying, developing and commercializing pharmaceutical products for the treatment of skin diseases with unmet needs. Its lead product candidate, VP-102, is a drug-device combination of topical solution of cantharidin. The Company also intends to develop second cantharidin-based product candidate, VP-103, for the treatment of plantar warts. The Company has completed one Phase II clinical trial of topical solution of cantharidin administered with the wooden stick part of a cotton-tipped swab. It also conducting another Phase II clinical trial of topical solution of cantharidin administered through applicator, which collectively refer to as VP-102, for the treatment of molluscum.

Popular Stocks	Price	Change
AMC Entertainment AMC	$18.9188 3.27%	3.27%
AT&T T	$27.367 0.32%	0.32%
AMD AMD	$126.62 1.29%	1.29%
Nvidia NVDA	$253.34 1.07%	1.07%
FuelCell FCEL	$4.4199 2.79%	2.79%
Micron Technology MU	$89.51 0.54%	0.54%
Ford F	$22.63 0.8%	0.8%
Apple AAPL	$169.1 1.73%	1.73%
NIO NIO	$30.35 6.01%	6.01%